【口服“感染通”预防急性呼吸道感染】

Zeitschrift fur Erkrankungen der Atmungsorgane Pub Date : 1990-01-01

P Luther, I Brachmann, D Werchan, C Wittig, H Tischner

{"title":"【口服“感染通”预防急性呼吸道感染】","authors":"P Luther, I Brachmann, D Werchan, C Wittig, H Tischner","doi":"","DOIUrl":null,"url":null,"abstract":"The efficacy of a newly developed polyvalent bacterial lysat vaccine \"Infectvac\" was tested in experimental studies in animals. It was shown that a local application (oral, aerogenic) prevent the animals from a lethal bacterial (S. pneumoniae) or viral (A/PR/8/34) infection. In first clinical trials a good compatibility of the drug was demonstrated.","PeriodicalId":76840,"journal":{"name":"Zeitschrift fur Erkrankungen der Atmungsorgane","volume":"175 2","pages":"95-9"},"PeriodicalIF":0.0000,"publicationDate":"1990-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Oral administration of \\\"Infectvac\\\" for prevention of acute respiratory tract infections].\",\"authors\":\"P Luther, I Brachmann, D Werchan, C Wittig, H Tischner\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The efficacy of a newly developed polyvalent bacterial lysat vaccine \\\"Infectvac\\\" was tested in experimental studies in animals. It was shown that a local application (oral, aerogenic) prevent the animals from a lethal bacterial (S. pneumoniae) or viral (A/PR/8/34) infection. In first clinical trials a good compatibility of the drug was demonstrated.\",\"PeriodicalId\":76840,\"journal\":{\"name\":\"Zeitschrift fur Erkrankungen der Atmungsorgane\",\"volume\":\"175 2\",\"pages\":\"95-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1990-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zeitschrift fur Erkrankungen der Atmungsorgane\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift fur Erkrankungen der Atmungsorgane","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

一种新开发的多价细菌裂解疫苗“感染”的有效性在动物实验研究中得到了检验。结果表明，局部应用(口服，空气源)可防止动物感染致命的细菌(肺炎链球菌)或病毒(a /PR/8/34)。在第一次临床试验中，证明了该药的良好相容性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

微信好友朋友圈 QQ好友复制链接

本刊更多论文

[Oral administration of "Infectvac" for prevention of acute respiratory tract infections].

The efficacy of a newly developed polyvalent bacterial lysat vaccine "Infectvac" was tested in experimental studies in animals. It was shown that a local application (oral, aerogenic) prevent the animals from a lethal bacterial (S. pneumoniae) or viral (A/PR/8/34) infection. In first clinical trials a good compatibility of the drug was demonstrated.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Zeitschrift fur Erkrankungen der Atmungsorgane

自引率

0.00%

发文量